Abstract: An assembly having an externally threaded pipe nipple with an inserted grommet couples to a motor frame and to a conduit box, supporting the conduit box to the motor frame and providing a pathway for the motor lead through the grommet and nipple into the conduit box. T conduit box configured to house motor lead connections to the incoming power supply. A sealing material, such as a fluid elastomeric material, is poured into the pipe nipple and allowed to cure. The grommet abuts against a stop portion of the pipe nipple, retaining the sealing material. A nut having external threads mates with internal threads of the pipe nipple. As the nut is rotated and tightened, it compresses the sealing material against the inner surface of the pipe nipple and against the motor lead wires, and thus sealing the electrical connections within the conduit box, from the motor and environment.

Abstract: The present invention relates generally to dissipation of shaft charge. According to an exemplary embodiment, the present invention provides a charge-dissipating device that includes a dissipation member disposed in an explosion-proof enclosure. When mounted to a rotatable shaft of an electric motor, for example, the dissipation member is configured to generally abut against the rotatable shaft. The dissipation member dissipates shaft-charge developed in the rotatable shaft during operation of the motor. By dissipating shaft charge, the likelihood of arcing and/or bearing current (Ib) occurrences are reduced or eliminated. In accordance with another exemplary embodiment, a transmission member is configured to impart a voltage signal onto the shaft.

Abstract: Composition of matter for application to a body surface or membrane to administer a N-(2,5-Disubstituted phenyl)-N′-(3-substituted phenyl)-N′-methyl guanidine by permeation through the body surface or membrane, the composition comprising the guanidine compound to be administered, at a therapeutically effective rate, optionally in combination with a permeation enhancer or mixture. Also disclosed are drug delivery devices and methods for the transdermal administration of a guanidine for the prevention of neuropathic pain, neuropsychological deficits resulting from cardiac surgery (CABG), and other neurological disorders.

Abstract: Composition of matter for application to a body surface or membrane to administer a N-(2,5-Disubstituted phenyl)-N′-(3-substituted phenyl)-N′-methyl guanidine by permeation through the body surface or membrane, the composition comprising the guanidine compound to be administered, at a therapeutically effective rate, optionally in combination with a permeation enhancer or mixture. Also disclosed are drug delivery devices and methods for the transdermal administration of a guanidine for the prevention of neuropathic pain, neuropsychological deficits resulting from cardiac surgery (CABG), and other neurological disorders.